COVID-19 Hastalarında Toraks BT Şiddet Skorları, CO-RADS, D Vitamini Düzeyleri ve Diğer Laboratuvar Parametreleri Arasındaki İlişki
PDF
Atıf
Paylaş
Talep
P: 104-110
Ağustos 2022

COVID-19 Hastalarında Toraks BT Şiddet Skorları, CO-RADS, D Vitamini Düzeyleri ve Diğer Laboratuvar Parametreleri Arasındaki İlişki

Turk J Osteoporos 2022;28(2):104-110
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih: 03.05.2021
Kabul Tarihi: 27.07.2021
Yayın Tarihi: 11.08.2022
PDF
Atıf
Paylaş
Talep

ÖZET

Amaç:

Bu çalışma, koronavirüs hastalığı-2019 (COVID-19) hastalarında laboratuvar parametreleri, toraks bilgisayarlı tomografisi (BT) şiddet skoru (CTSS) ve COVID-19 Raporlama ve Veri Sistemi (CO-RADS) arasındaki ilişkiyi belirlemeyi amaçlamaktadır.

Gereç ve Yöntem:

COVID-19 semptomları ile acil servise başvuran ve başvuru anında toraks BT çekilmiş olan, polimeraz zincir reaksiyon testi ile COVID-19 olduğu doğrulanan 91 hasta çalışmaya dahil edildi. Hastaların 25-hydroksivitamin D [25(OH)D] seviyeleri, eritrosit sedimantasyon hızı (ESR), C-reaktif protein (CRP), D-dimer, glikoz, ferritin, kreatinin, alanin aminotransferaz, aspartat aminotransferaz, fosfor ve kalsiyum seviyeleri ile birlikte CO-RADS ve CTSS verileri retrospektif olarak kaydedildi. Laboratuvar parametrelerinin radyolojik bulgularla korelasyonu incelendi.

Bulgular:

CTSS ile yaş, ESR, CRP, D-dimer arasında pozitif korelasyon bulunurken, CTSS ile lenfosit sayısı arasında negatif korelasyon bulundu. Yüksek CTSS seviyeleri olan hastalarda daha yüksek ESR, CRP, D-dimer, ferritin değerleri ve daha düşük lenfosit sayısı ile kalsiyum seviyeleri vardı. Tipik CO-RADS tutulumu olan hastalar daha yüksek sedimantasyon, CRP, glikoz ve ferritin seviyelerine ve daha düşük lenfosit sayısına sahipti. 25(OH)D düzeyi ile CO-RADS ve CTSS arasında anlamlı bir ilişki saptanmadı.

Sonuç:

Bu çalışmanın sonuçları, düşük lenfosit sayısı, yüksek D-dimer, sedimantasyon, ferritin ve CRP düzeylerinin COVID-19 hastalarında şiddetli akciğer tutulumunun belirleyicileri olduğunu düşündürmektedir. Hipokalsemi, BT ile değerlendirilen COVID-19 hastalarında ciddi akciğer tutulumunun bir belirteci olarak da düşünülebilir. D vitamini eksikliği ve COVID-19 pnömonisinin ilişkisi ileri çalışmalarda araştırılmalıdır.

References

1
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. 
2
World Health Organization Coronavirus disease; 2019. (COVID-19): situation report.
3
Soraya GV, Ulhaq ZS. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis. Med Clin (Barc) 2020;155:143-51. 
4
Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health 2020;13:1373-80. 
5
Biesalski HK. Vitamin D deficiency and co-morbidities in COVID-19 patients – a fatal relationship? NFS J 2020;20:10-21.
6
Sun JK, Zhang WH, Zou L, Liu Y, Li JJ, Kan XH, et al. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging (Albany NY) 2020;12:11287-95. 
7
ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection 2020 Available from. https://www.acr.org/ Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest- Radiography-and-CT-for-Suspected-COVID19-Infection.
8
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. 
9
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-20. 
10
Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, et al. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society. Radiology 2020;296:172-80. 
11
Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA - Secondary Publication. J Thorac Imaging 2020;35:219-27. 
12
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020;296:E32-40.
13
Islam N, Ebrahimzadeh S, Salameh JP, Kazi S, Fabiano N, Treanor L, et al. Thoracic imaging tests for the diagnosis of COVID-19. Cochrane Database Syst Rev 2021;3:CD013639.
14
Zimmerman M. Handreiking Standaardverslag CT-thorax COVID inclusief CO-RADS en CT-score. https://www.radiologen.nl/secties/netwerk-covid-19/documenten/handreiking-standaardverslag-ct-t orax-covid-inclusief-co-rads (Accessed March 5, 2021).
15
Kwee RM, Adams HJA, Kwee TC. Chest CT in Patients with COVID-19: Toward a Better Appreciation of Study Results and Clinical Applicability. Radiology 2021;298:E113-4. 
16
Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology 2020;295:715-21. 
17
Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Invest Radiol 2020;55:327-31. 
18
Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol 2020;30:4407-16.
19
Wong HYF, Lam HYS, Fong AH, Leung ST, Chin TW, Lo CSY, et al. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology 2020;296:E72-8. 
20
Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Invest Radiol 2020;55:332-9. 
21
Liu Z, Jin C, Wu CC, Liang T, Zhao H, Wang Y, et al. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia. Korean J Radiol 2020;21:736-45.
22
Radujkovic A, Hippchen T, Tiwari-Heckler S, Dreher S, Boxberger M, Merle U. Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020;12:2757.
23
Mohan M, Cherian JJ, Sharma A. Exploring links between vitamin D deficiency and COVID-19. PLoS Pathog 2020;16:e1008874. 
24
Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol 2020;8:570.
25
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017;356:i6583.
26
D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, et al. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients 2020;12:1359. 
27
Munshi R, Hussein MH, Toraih EA, Elshazli RM, Jardak C, Sultana N, et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol 2021;93:733-40.
28
Sankaran RT, Mattana J, Pollack S, Bhat P, Ahuja T, Patel A, et al. Laboratory abnormalities in patients with bacterial pneumonia. Chest 1997;111:595-600. 
29
Di Filippo L, Formenti AM, Rovere-Querini P, Carlucci M, Conte C, Ciceri F, et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine 2020;68:475-8. 
30
Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
31
Fong J, Khan A. Hypocalcemia: updates in diagnosis and management for primary care. Can Fam Physician 2012;58:158-62.
32
Lippi G, Favaloro EJ. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost 2020;120:876-8.
33
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020;127:104370. 
34
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020;71:762-8. 
35
Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis 2020;96:467-4. 
36
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41.
37
Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia 2020;63:2102-11.
38
Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020;95:E131-4.
39
Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 2020;5:33.
40
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12:8.
41
Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 2002;169:4288-97. 
42
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta 2020;506:145-8.
43
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol 2020;99:1205-8. 
44
Orsi MA, Oliva AG, Cellina M. Radiology Department Preparedness for COVID-19: Facing an Unexpected Outbreak of the Disease. Radiology 2020;295:E8. 
2024 ©️ Galenos Publishing House